Stephen Hahn, FDA commissioner (Alex Brandon/AP Images)

August 28, 2020 02:05 PM EDT

FDA commissioner Hahn ousts agency’s new chief spokesperson as plasma controversy continues to smolder

Jason Mast

Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B

AbbVie doubles down on siRNA with $335M upfront bet on ADARx

Advocacy groups and experts call for decade-long ban on germline editing

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

CRISPR patent spat revived by federal appeals court ruling